USFDA conducts inspection at Solara Active Pharma Sciences’ Visakhapatnam API manufacturing facility

30 Jan 2023 Evaluate

The United States Food and Drug Administration (USFDA) has conducted an inspection at the new state-of-the-art multipurpose API manufacturing facility of Solara Active Pharma Sciences at Visakhapatnam (Vizag), Andhra Pradesh. The Agency, with its designated investigator, inspected the facility from January 23, 2023 to January 26, 2023. The inspection established that the site is in an Acceptable State of Compliance with Zero Form 483 inspectional observations from the agency.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

545.35 -11.10 (-1.99%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×